TG Therapeutics GAAP EPS of -$0.07 misses by $0.03, revenue of $63.47M beats by $8.86M
by
Contributor since / Followers
Contributor since / Followers
8 months ago
- TG Therapeutics press release (NASDAQ:TGTX): Q1 GAAP EPS of -$0.07 misses by $0.03.
- Revenue of $63.47M (+713.7% Y/Y) beats by $8.86M.
- Total revenue for Q1 2024 of $63.5 million, including a $12.5 million milestone payment for BRIUMVI launch in first EU country